Literature DB >> 15283824

The use of recalcified citrated whole blood -- a pragmatic approach for thromboelastography in children.

Sanjay Rajwal1, Mike Richards, Moira O'Meara.   

Abstract

BACKGROUND: Thromboelastography (TEG) is an established way of monitoring the coagulation status of children and adults requiring blood products during surgery. Serial measurements are performed using a nearside machine and blood product prescription may be titrated against changes in TEG. There may also be useful applications when the patient is remote from the TEG machine but these are limited because TEG is usually performed on fresh native whole blood within 6 min of venepuncture. Citrated whole blood can be used for TEG if transport time is more than 6 min. We wished to establish whether TEG parameters for citrated whole blood were comparable with those of native whole blood in healthy children.
METHODS: Blood was obtained from 14 healthy children undergoing minor surgical procedures, at the time of intravenous cannula insertion for anaesthesia. Each sample was divided: TEG was performed on part of the sample in its fresh native state at 6 min and second portion of the sample was citrated, kept at room temperature and TEG was performed at 30 min after recalcification.
RESULTS: There was a significant difference in TEG parameters (r, k, alpha, MA and LY30) for fresh native whole blood and recalcified citrated whole blood (paired t-test).
CONCLUSIONS: The normal range for fresh native whole blood TEG parameters is well established, which is routinely used in practice. There was a significant difference between TEG parameters for fresh native whole blood and citrated whole blood. We recommend that a specific normal range be established for citrated whole blood to enable it to be used in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15283824     DOI: 10.1111/j.1460-9592.2004.01275.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  5 in total

Review 1.  Coagulopathy and transfusion therapy in pediatric liver transplantation.

Authors:  Mirco Nacoti; Davide Corbella; Francesco Fazzi; Francesca Rapido; Ezio Bonanomi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

2.  Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood.

Authors:  Riccardo Sfriso; Anjan Bongoni; Yara Banz; Nikolai Klymiuk; Eckhard Wolf; Robert Rieben
Journal:  J Vis Exp       Date:  2017-09-05       Impact factor: 1.355

Review 3.  Coagulopathy: its pathophysiology and treatment in the injured patient.

Authors:  Brandon H Tieu; John B Holcomb; Martin A Schreiber
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

4.  MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model.

Authors:  Lorenz Jenny; József Dobó; Péter Gál; Gábor Pál; Wilbur A Lam; Verena Schroeder
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

5.  TEG® and ROTEM® in trauma: similar test but different results?

Authors:  Ajith Sankarankutty; Bartolomeu Nascimento; Luis Teodoro da Luz; Sandro Rizoli
Journal:  World J Emerg Surg       Date:  2012-08-22       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.